Financials

  • Market Capitalization 8.09 B
  • Employee 3 100
  • Founded 1976
  • CEO Charles R. Kummeth
  • Website www.bio-techne.com
  • Headquarter Minnesota, United States
  • FIGI BBG000C15114
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
75.74
Fiyat/satışlar oranı
6.8
Hisse başına temettü
0.08
Temettü getirisi %
1.07

Bio-Techne Corp - Common Stock

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

Haberler